About IGEA Pharma B.V.
IGEA Pharma BV is a leading player in Alzheimer’s Disease and diabetes prevention. More than 20 years of research and studies have provided access to an effective biomedical solution to fight against Alzheimer’s Disease.
About IGEA Research Corporation
IGEA Research Corporation is an IGEA Pharma BV subsidiary.
IGEA’s leveraging on a patent-pending technology offers the possibility to measure and control levels of Free Copper II in the bloodstream. Free Copper II is a major recognized modifiable risk factor for the Alzheimer’s Disease.